Literature DB >> 24062883

The treatment of acute myocardial infarction: the Past, the Present, and the Future.

Eugene Braunwald1.   

Abstract

Since Herrick's description of the clinical picture of acute myocardial infarction exactly one century ago (1912), there have been three phases of therapy: Phase 1 (1912-1961, bed rest and 'expectant' treatment); Phase 2 (1961-1974, the coronary care unit); and Phase 3 (1975-present, myocardial reperfusion). We are now on the cusp of Phase 4, which comprises efforts to reduce myocardial perfusion injury as well as regenerative medicine.

Entities:  

Keywords:  Myocardial infarction; coronary care unit; myocardial reperfusion; reperfusion injury

Year:  2012        PMID： 24062883      PMCID： PMC3760555          DOI： 10.1177/2048872612438026

Source DB:  PubMed          Journal:  Eur Heart J Acute Cardiovasc Care        ISSN： 2048-8726


  31 in total

1.  Primary stent implantation compared with primary balloon angioplasty for acute myocardial infarction: a meta-analysis of randomized clinical trials.

Authors:  M M Zhu; A Feit; H Chadow; M Alam; T Kwan; L T Clark
Journal:  Am J Cardiol       Date:  2001-08-01       Impact factor: 2.778

2.  Remote postconditioning. Brief renal ischemia and reperfusion applied before coronary artery reperfusion reduces myocardial infarct size via endogenous activation of adenosine receptors.

Authors:  F Kerendi; H Kin; M E Halkos; R Jiang; A J Zatta; Z-Q Zhao; R A Guyton; J Vinten-Johansen
Journal:  Basic Res Cardiol       Date:  2005-06-17       Impact factor: 17.165

3.  Factors influencing infarct size following experimental coronary artery occlusions.

Authors:  P R Maroko; J K Kjekshus; B E Sobel; T Watanabe; J W Covell; J Ross; E Braunwald
Journal:  Circulation       Date:  1971-01       Impact factor: 29.690

4.  The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings.

Authors: 
Journal:  N Engl J Med       Date:  1985-04-04       Impact factor: 91.245

5.  Modification of myocardial infarction size after coronary occlusion.

Authors:  P R Maroko; E Braunwald
Journal:  Ann Intern Med       Date:  1973-11       Impact factor: 25.391

Review 6.  Clinical efforts to reduce myocardial infarct size--the next step.

Authors:  Eugene Braunwald
Journal:  J Cardiovasc Pharmacol Ther       Date:  2011 Sep-Dec       Impact factor: 2.457

7.  Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial.

Authors:  Hans Erik Bøtker; Rajesh Kharbanda; Michael R Schmidt; Morten Bøttcher; Anne K Kaltoft; Christian J Terkelsen; Kim Munk; Niels H Andersen; Troels M Hansen; Sven Trautner; Jens Flensted Lassen; Evald Høj Christiansen; Lars R Krusell; Steen D Kristensen; Leif Thuesen; Søren S Nielsen; Michael Rehling; Henrik Toft Sørensen; Andrew N Redington; Torsten T Nielsen
Journal:  Lancet       Date:  2010-02-27       Impact factor: 79.321

Review 8.  Aspiration thrombectomy with primary PCI for STEMI: review of the data and current guidelines.

Authors:  Bruce R Brodie
Journal:  J Invasive Cardiol       Date:  2010-10       Impact factor: 2.022

Review 9.  Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials.

Authors:  Ellen C Keeley; Judith A Boura; Cindy L Grines
Journal:  Lancet       Date:  2003-01-04       Impact factor: 79.321

10.  The "no-reflow" phenomenon after temporary coronary occlusion in the dog.

Authors:  R A Kloner; C E Ganote; R B Jennings
Journal:  J Clin Invest       Date:  1974-12       Impact factor: 14.808
View more
  18 in total

1.  Myocardial repair around-the-clock.

Authors:  Umesh C Sharma; John M Canty
Journal:  Circ Res       Date:  2014-05-23       Impact factor: 17.367

2.  Cardiovascular science: opportunities for translating research into improved care.

Authors:  Eugene Braunwald
Journal:  J Clin Invest       Date:  2013-01-02       Impact factor: 14.808

3.  [Immunity and inflammation in atherosclerosis].

Authors:  D Wolf; K Ley
Journal:  Herz       Date:  2019-04       Impact factor: 1.443

Review 4.  Thrombus aspiration in acute myocardial infarction: Rationale and indication.

Authors:  Gennaro Sardella; Rocco Edoardo Stio
Journal:  World J Cardiol       Date:  2014-09-26

5.  Current Status of Novel Biomarkers for the Diagnosis of Acute Kidney Injury: A Historical Perspective.

Authors:  Benjamin R Griffin; Katja M Gist; Sarah Faubel
Journal:  J Intensive Care Med       Date:  2019-01-17       Impact factor: 3.510

Review 6.  Cardiac fibrosis in regenerative medicine: destroy to rebuild.

Authors:  Gianluca Lorenzo Perrucci; Erica Rurali; Giulio Pompilio
Journal:  J Thorac Dis       Date:  2018-07       Impact factor: 2.895

Review 7.  Immunity and Inflammation in Atherosclerosis.

Authors:  Dennis Wolf; Klaus Ley
Journal:  Circ Res       Date:  2019-01-18       Impact factor: 17.367

Review 8.  Management of ST Elevation Myocardial Infarction (STEMI) in Different Settings.

Authors:  Rod Partow-Navid; Narut Prasitlumkum; Ashish Mukherjee; Padmini Varadarajan; Ramdas G Pai
Journal:  Int J Angiol       Date:  2021-03-24

Review 9.  Resolution-promoting autacoids demonstrate promising cardioprotective effects against heart diseases.

Authors:  Roddy Hiram
Journal:  Mol Biol Rep       Date:  2022-02-10       Impact factor: 2.742

Review 10.  Balloon Angioplasty - The Legacy of Andreas Grüntzig, M.D. (1939-1985).

Authors:  Matthias Barton; Johannes Grüntzig; Marc Husmann; Josef Rösch
Journal:  Front Cardiovasc Med       Date:  2014-12-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.